Clinical trial
Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study
NCT03655704 is registered in ClinicalTrials.gov with Steeve Provencher as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study
- Lead sponsor
- Steeve Provencher
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 22, 2019
- Completion date
- December 13, 2021
- Enrollment
- 7 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.